Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Net Cash Flow (2016 - 2025)

Bio-Techne (TECH) has 17 years of Net Cash Flow data on record, last reported at $27.5 million in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 708.09% year-over-year to $27.5 million; the TTM value through Dec 2025 reached -$16.2 million, down 136.03%, while the annual FY2025 figure was -$1.5 million, 94.21% up from the prior year.
  • Net Cash Flow reached $27.5 million in Q4 2025 per TECH's latest filing, up from -$16.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $54.4 million in Q2 2023 and bottomed at -$46.9 million in Q1 2022.
  • Average Net Cash Flow over 5 years is $650600.0, with a median of $5.6 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: crashed 606.1% in 2023, then soared 708.09% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $12.4 million in 2021, then crashed by 163.62% to -$7.9 million in 2022, then plummeted by 177.2% to -$22.0 million in 2023, then skyrocketed by 79.4% to -$4.5 million in 2024, then skyrocketed by 708.09% to $27.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $27.5 million in Q4 2025, -$16.0 million in Q3 2025, and $8.2 million in Q2 2025.